PMID: 386347Aug 1, 1979Paper

Amino acid sequence and physicochemical similarities between streptococcal M protein and mammalian tropomyosin

Proceedings of the National Academy of Sciences of the United States of America
B HoseinV A Fischetti


The amino-terminal sequences of two peptides of type 24 streptococcal M protein show similarities with that of rabbit skeletal muscle tropomyosin, having up to 40% identical residues and probabilities of occurring by chance as low as P less than 10(-5). In addition, a hexapeptide (Glu-Ala-Glu-Lys-Ala-Ala) that is found five times in the M24 protein was shown to be identical to a sequence in tropomyosin. Similarities are also seen in the amino acid compositions and physicochemical properties of the two proteins. The amino-terminal sequences of peptides from another bacterial surface protein, staphylococcal protein A, are highly correlated with segments of two other myofibrillar proteins, rabbit actin (P less than 10(-7)) and rabbit myosin A1 light chain (P less than 10(-6)). The data presented suggest that a close structural relationship exists between mammalian muscle proteins and the biologically active surface proteins of staphylococci and streptococci. In addition, the correlation between sequences in M protein and tropomyosin represents direct evidence of a structural similarity at a molecular level between a streptococcal protein and a mammalian muscle component and may therefore prove relevant to the pathogenicity of the ...Continue Reading


Jul 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·E H BeacheyA H Kang
Jan 1, 1977·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·W C Barker, M O Dayhoff
Jan 1, 1976·Annual Review of Biochemistry·H G Mannherz, R S Goody
Jan 1, 1978·Annual Review of Biochemistry·J M DiRienzoM Inouye
Apr 9, 1976·Journal of Molecular Evolution·M Ycas
Oct 25, 1975·Journal of Molecular Biology·A D McLachlanL B Smillie
May 15, 1974·European Journal of Biochemistry·G Frank, A G Weeds
Sep 25, 1972·European Journal of Biochemistry·I BjörkJ Sjöquist
Oct 1, 1965·Proceedings of the National Academy of Sciences of the United States of America·E N Fox, M K Wittner
Nov 1, 1969·The Journal of Experimental Medicine·J SwansonE C Gotschlich
Aug 1, 1970·Journal of Ultrastructure Research·D Zucker-Franklin
Oct 1, 1966·The Journal of Experimental Medicine·J B Zabriskie, E H Freimer
Aug 1, 1959·The Journal of Experimental Medicine·R C LANCEFIELD
Jul 1, 1952·The Journal of Experimental Medicine·R C LANCEFIELD, G E PERLMANN

❮ Previous
Next ❯


Aug 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·G N PhillipsV A Fischetti
Sep 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·B N ManjulaV A Fischetti
Mar 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·D W DunneK A Joiner
Jun 1, 1985·The Journal of Experimental Medicine·V A FischettiJ R Scott
Jun 9, 2005·The Journal of Experimental Medicine·Emil C Gotschlich, Vincent A Fischetti
Mar 4, 2014·Indian Heart Journal·Rajendra Tandon
Oct 30, 1986·Biochemical and Biophysical Research Communications·B N Manjula, V A Fischetti
Feb 15, 1986·Archives of Biochemistry and Biophysics·J M Chalovich, V A Fischetti
Aug 12, 2016·Proceedings of the National Academy of Sciences of the United States of America·Chelsea M StewartPartho Ghosh
Jul 1, 1982·Angiology·S DeCarvalho
Nov 1, 1979·Hospital Practice·E H BeacheyA L Bisno
Jul 1, 1989·Clinical Microbiology Reviews·V A Fischetti
Nov 1, 1985·Infection and Immunity·R S BerkL Hazlett

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.